NICOLO', MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 5.825
Totale 5.825
Nazione #
IT - Italia 5.825
Totale 5.825
Città #
Genova 4.231
Rapallo 707
Genoa 620
Vado Ligure 236
Bordighera 31
Totale 5.825
Nome #
Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy. 153
Pleomorphic adenocarcinoma of the ciliary epithelium: a clinicopathological, immunohistochemical, ultrastructural, DNA-ploidy and comparative genomic hybridization analysis of an unusual case. 150
I-Maculaweb: A Tool to Support Data Reuse in Ophthalmology 148
Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin 130
Yellow micropulse laser in diabetic macular edema: a short-term pilot study. 129
Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin 128
Choroidal metastasis from a cutaneous malignant melanoma regressed after cisplatin therapy. 122
Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approach. 120
Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to age-related macular degeneration. 117
Marker gene transfer and oncolysis of human Y79 retinoblastoma cells mediated by herpes simplex virus mutants. 112
Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy 112
Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform 112
Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). 110
Follicular large-cell lymphoma of the orbit: a clinicopathologic, immunohistochemical and molecular genetic description of one case. 110
Choroidal vascular flow area in central serous chorioretinopathy using swept-source optical coherence tomography angiography 110
Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes. 109
Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. 107
Chorioretinal folds: a proposed diagnostic algorithm 106
Eales Disease Associated with Serpiginous Choroiditis 105
Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series. 103
Early swept-source optical coherence tomography angiography findings in unilateral acute idiopathic maculopathy 103
Response to anti-VEGF-A treatment of endothelial cells in vitro 101
Morphological, physiological, and biochemical changes in rhodopsin knockout mice. 100
Response to anti-VEGF-A treatment of retinal pigment epithelial cells in vitro. 99
Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunit. 98
Detection of tenascin-C in surgically excised choroidal neovascular membranes. 98
Silent occult choroidal vascular abnormalities. 95
Choroidal hemangioma treated with photodynamic therapy using verteporfin: report of a case. 93
A Web-tool to manage ophtalmologic electronic health record 93
Inhibition of a vascular ocular tumor growth by IL-12 gene transfer. 92
Re: Evaluation of choroidal changes in adolescent idiopathic scoliosis using enhanced depth imaging optical coherence tomography 90
Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System 90
Chorioretinal folds: associated disorders and a related maculopathy. 88
Allograftreaction after penetrating keratoplasty 86
Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (pride study) 86
The Effects of Ocular Perfusion Pressure Variations on a Case of Circumscribed Choroidal Hemangioma Affected by Primary Open-Angle Glaucoma 86
Diagnostic and Therapeutic Challanges 83
Choroidal vascular reactivity in central serous chorioretinopathy 82
Subthreshold laser grid photocoagulation for the treatment of diabetic macular edema 78
Real-life data in the treatment of neovascular age-related macular degeneration. Results from the I-maculaweb registry evaluated in a single Italian Medical Retina center. 77
Reply 76
Multiple bilateral choroidal metastatic tumors from a small-cell neuroendocrine carcinoma of unknown primary site. 75
Solitary fibrous tumor of the inguinal region: a clinicopathological, light-microscopic, immunohistochemical, electron microscopic and flow-cytometric DNA study. 74
Retinal vascular reactivity in central serous chorioretinopathy 74
Real-Life Management of Diabetic Macular Edema with Dexamethasone Intravitreal Implant: A Retrospective Analysis of Long-Term Clinical Outcomes 74
Malignant melanoma of soft tissues (clear cell sarcoma) of the foot. Is MRI able to perform a specific diagnosis? Report of one case and review of the radiological literature. 72
Photodynamic Therapy of Rabbit Corneal Neoascularization with Photosensitizer Conjugated to Antibody against the Extradomain–B of Fibronectin 68
Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT 68
Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization 65
Photodynamic Therapy of Choroidal Neovascularization Using Verteporfin in Pathologic Myopia: Analysis of Visual Outcomes 61
Choroidal Melanoma treatment with proton beam: first nine years of experience of the Genoa Ocular Oncology Group 60
Vascular Density and Retinal Function in patients with Retinitis Pigmentosa evaluated by swept-source OCT angiography and microperimetry 58
"Retinal nerve fiber layer analysis in unaffected first-degree relatives of schizophrenia patients" 56
Occhioallaretina.it 54
La cheratotomia radiale per la riduzione della miopia inferiore alle 3 diottrie. 49
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview 45
Teprotumumab. Anti-insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, Treatment of thyroid eye disease 43
Gli impianti drenanti per la terapia dei glaucomi refrattari 41
Clinical efficacy and safety of ranibizumab in the treatment of wet age-related macular degeneration 41
Risuteganib. Broad-spectrum integrin inhibitor, Treatment of diabetic macular edema, Treatment of dry age-related macular degeneration 41
Effects of the hand-grip test on retinal vascular and structural parameters measured by optical coherence tomography in healthy subjects 40
Ocular biometric parameters changes and choroidal vascular abnormalities in patients with neurofibromatosis type 1 evaluated by OCT-A 39
Correspondence. 37
Bilateral choroidal detachment and myopic shift after acetazolamide intake for laser capsulotomy 36
Efficacy of a New Commercial Ocular Spray Containing Oftasecur Citrus Extract for Reducing Microbial Load in the Conjunctiva of Patients Receiving Intravitreal Injections 34
Inhibitory action of antidiabetic drugs on the free radical production by the rod outer segment ectopic aerobic metabolism 31
The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series 30
Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases 29
Retinal Pigment Epithelium Tear after Glaucoma Surgery 22
Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure 22
Razumab-the role of biosimilars for the treatment of retinal diseases 21
The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases 19
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 19
An update on conbercept to treat wet age-related macular degeneration 16
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography 16
Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis 14
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak 14
Choroidal changes in intermediate age-related macular degeneration patients with drusen or pseudodrusen 14
Early DMO: a predictor of poor outcomes following cataract surgery in diabetic patients. The DICAT-II study 13
Brolucizumab: a novel anti-VEGF humanized single-chain antibody fragment for treating w-AMD 13
MiR-126 Mimic Counteracts the Increased Secretion of VEGF-A Induced by High Glucose in ARPE-19 Cells 10
Current pharmacological treatment options for central serous chorioretinopathy: A review 10
Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation 8
Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy 7
The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases 6
Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts 6
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 5
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials 4
PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration 4
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials 4
Reply [4] 2
Totale 5.951
Categoria #
all - tutte 21.045
article - articoli 20.409
book - libri 0
conference - conferenze 499
curatela - curatele 0
other - altro 137
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.382 0 0 59 88 120 148 227 105 131 252 184 68
2020/2021562 39 64 80 39 30 35 26 55 37 82 37 38
2021/2022776 18 60 63 62 30 43 45 181 55 73 41 105
2022/2023859 76 58 18 78 120 152 20 70 134 11 105 17
2023/2024513 18 82 14 73 41 78 15 54 25 14 18 81
2024/2025278 86 136 56 0 0 0 0 0 0 0 0 0
Totale 5.951